Dr. Saad on Apalutamide Combination for Castration-Resistant Prostate Cancer OncLive 1:47 7 years ago 798 Скачать Далее
Fred Saad, MD, details safety concerns when presenting apalutamide + ADT to nmCRPC patients OBRoncology 3:14 4 years ago 89 Скачать Далее
Kim N. Chi, MD, outlines the safety profile of apalutamide OBRoncology 1:03 3 years ago 43 Скачать Далее
Dr. Agarwal on the Safety Profile of Enzalutamide/Talazoparib in mCRPC OncLive 1:02 4 years ago 371 Скачать Далее
Dr. Stenzl on the Safety Profile of Enzalutamide/ADT in mHSPC OncLive 1:24 4 years ago 139 Скачать Далее
Dr. Kohli on the Use of Enzalutamide and Apalutamide in mHSPC OncLive 1:50 4 years ago 446 Скачать Далее
Comparing Apalutamide and Enzalutamide in Real-World Treatment of mCSPC GU Oncology Now 8:09 3 months ago 272 Скачать Далее
Safety outcomes of darolutamide vs apalutamide and enzalutamide in nmCRPC VJOncology 2:38 4 years ago 1 251 Скачать Далее
Dr. Azad on the Benefit of Adding Enzalutamide to ADT in mHSPC OncLive 1:03 3 years ago 725 Скачать Далее
Live from ASCO: Apalutamide for Castration-Sensitive Prostate Cancer NEJM Group 2:50 5 years ago 2 535 Скачать Далее
